Amit B. Shah insider trades: Oncotelic Therapeutics (OTLC) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Amit reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | OTLC | ↑ Buy | 20,000 | $0.05 | $1K | Direct | Jun 22, 2026 (0d) |
| Nov 24, 2020 | MATN | ↑ Buy | 60,000 | $0.19 | $12K | Direct | Nov 24, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OTLC insiders
Open-market trades in the last 12 months
About Amit B. Shah's insider trades
Amit B. Shah is CFO at Oncotelic Therapeutics (OTLC). Since Nov 24, 2020, Amit has reported 2 open-market purchases worth $13K and no sales on SEC Form 4. In the last 12 months: 1 buy ($1K).
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OTLC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.